---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-028678"
form_type: "8-K"
ticker: "DFTX"
cik: "0001813814"
company_name: "Definium Therapeutics, Inc."
filed_at: "2023-06-16T23:59:59+00:00"
generated_at: "2026-06-13T23:06:39.215201+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# MindMed annual meeting adjourned; potential Nasdaq delisting risk from quorum issue

## Summary
- 2023 annual general meeting on June 15 failed due to lack of 33 1/3% quorum; reconvened for June 21 at 10 a.m. ET.
- Articles allow meeting to proceed with whatever persons present if quorum not met within 30 minutes of reconvened meeting.
- Nasdaq may issue non-compliance letter if less than 33 1/3% present; company has 45 days to submit plan, possible 180-day extension.
- Potential delisting would negatively impact liquidity and market price; company believes it can regain compliance but no assurance.

## SEC filing metadata
- accession: 0000950170-23-028678
- form_type: 8-K
- ticker: DFTX
- cik: 0001813814
- company_name: Definium Therapeutics, Inc.
- filed_at: 2023-06-16T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1813814/000095017023028678/0000950170-23-028678-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1813814/000095017023028678/mnmd-20230616.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-028678
- JSON: https://secwatch.observer/filing/0000950170-23-028678.json
- Plain text: https://secwatch.observer/filing/0000950170-23-028678.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.